Key result
Preoperative TyG-BMI was not independently associated with the development of low estimated glomerular filtration rate (OR 1.003) in patients with coronary heart disease after percutaneous coronary intervention.
Why the study?
The relationship between preoperative TyG-BMI and long-term eGFR in patients with CHD after PCI without CKD was unclear.
Does preoperative Triglyceride glucose-body mass index (TyG-BMI) predict low eGFR in patients with coronary heart disease after percutaneous coronary intervention?
Case-Control (n=1,020)
No
Does preoperative Triglyceride glucose-body mass index (TyG-BMI) predict low eGFR in patients with coronary heart disease after percutaneous coronary intervention?
Answers are grounded in this paper and cite their sources.
Preoperative TyG-BMI is not an independent predictor of long-term eGFR decline in patients with coronary heart disease following PCI, suggesting other tools are needed for renal risk stratification in this population.
Background: There exists a close and complex bidirectional relationship between cardiovascular disease (CVD) and chronic kidney disease (CKD). CVD is a well-established risk factor for CKD, while the Triglyceride glucose-body mass index (TyG-BMI) has been considered as a predictor of cardiovascular events. This was a retrospective case-control study. This study aimed to investigate the relationship between preoperative TyG-BMI and estimated glomerular filtration rate(eGFR) during follow-up in patients with coronary heart disease (CHD) after percutaneous coronary intervention (PCI). Methods: This study was performed in 1020 patients with CHD after PCI without CKD from 01/01/2015 to 01/01/2025. We performed multifaceted analyses of the association between preoperative TyG-BMI and eGFR, including multiple linear regression for continuous eGFR outcomes, logistic regression to identify whether TyG-BMI independently influenced categorical eGFR status and quantify the magnitude of this association, and restricted cubic spline (RCS) analysis to explore non-linear relationships. Low eGFR (<60 mL/(min*1.73m²)) was set as the outcome variable, and was obtained from the latest follow-up. Results: for nonlinear > 0.05). Conclusion: Preoperative TyG-BMI exerted no direct independent effect on long-term outcome of eGFR. It is unlikely that TyG-BMI serves as a primary determinant of CKD in patients with CHD after PCI. Future studies should evaluate combined risk models.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) conducted a case-control in Coronary heart disease (CHD) post-percutaneous coronary intervention (PCI) (n=1,020). Preoperative Triglyceride glucose-body mass index (TyG-BMI) was evaluated on Low eGFR (<60 mL/(min*1.73m²)) (OR 1.003, 95% CI 0.977-1.009, p=0.369). Preoperative TyG-BMI was not independently associated with the development of low estimated glomerular filtration rate (OR 1.003) in patients with coronary heart disease after percutaneous coronary intervention.
Synapse has enriched 10 related papers. Consider them for comparative context: